Skip to main content

The Future of FDA and Cannabis Regulation (now available for On-Demand CLE)

Regulation of cannabis by the federal government, specifically the Food & Drug Administration, was unthinkable less than a decade ago, but it will someday soon be a reality. The FDA is already aware of the non-approved uses of cannabis to treat conditions such as AIDS wasting, epilepsy, neuropathic pain, and several others. The agency has also approved one cannabis-derived drug product: Epidiolex (cannabidiol), used to treat seizures, and three synthetic cannabis-related drug products: Marinol (dronabinol), Syndros (dronabinol), and Cesamet (nabilone), all of which treat nausea due to chemotherapy. These approvals don’t signal a trend toward legalization of cannabis, but they do show that the FDA’s studies of cannabis are starting to bear some fruit.

The most recent official guidance from the FDA regarding cannabis regulation was published in January 2021. In this communication, the FDA reassured readers that they are aware of the public interest in using cannabis to develop treatments and consumer products. But the FDA is known for being cautious. The stakes for getting it wrong are high when measured in lives lost. To make matters more complicated, the public is divided on the benefits and dangers of cannabis. However, with other countries experimenting with or outright approving cannabis, the FDA is clearly feeling the pressure to move on the issue of cannabis regulation in the United States.

This CLE will discuss the FDA’s current stance and what needs to happen to move the needle on the FDA’s regulation of cannabis. The discussion will be led by a panel of three cannabis regulation experts. Amber Littlejohn will serve as moderator. Littlejohn is the executive director of the Minority Cannabis Business Association in Washington, D.C., and director of the U.S. Hemp Authority. Patrick Goggin and Garrett Graff will round out the panel. Goggin is a Senior Attorney with the Hoban Law Group specializing in assisting both large and small cannabis businesses. Graff is a partner is Moye White LLP and nationally recognized as a Cannabis Law Trailblazer by National Law Journal.

This program is a must for anyone in the professional cannabis business who is eagerly awaiting FDA regulation and all the changes that come with it.


The Future of FDA and Cannabis Regulation


Popular posts from this blog

International Cannabis Bar Association Weclomes Shahiedah Shabazz as New Executive Director

International Cannabis Bar Association Welcomes  Shahiedah Shabazz as New Executive Director San Francisco, CA – The International Cannabis Bar Association (INCBA) is pleased to announce and welcome Shahiedah Shabazz as its new Executive Director. Shahiedah joins INCBA after working as a municipal attorney in Southern California and as an Associate in top law firms, including at ArentFox Schiff LLP, where she was the firm’s cannabis regulatory expert and co-lead of the firmwide Cannabis Industry Group. With her 15-year career as an attorney, training in organizational leadership, and deep knowledge of the cannabis industry, Shahiedah brings a wealth of expertise and leadership to the organization. In prior roles, she worked as a transactional attorney and regulatory attorney, helping cannabis operators obtain and maintain state and local licenses, respond to enforcement actions, and successfully complete mergers and acquisitions. She also regularly facilitated communication between pri

Jessica McElfresh, INCBA Member and Board of Director, interviewed regarding a new California law banning employers from marijuana screening.

Jessica McElfresh, INCBA Member who also holds a seat on our Board of Directors , was interviewed by 10News ABC in San Diego (KGTV) regarding a new California law banning employers from marijuana screening.  "This is a big step." Jessica McElfresh is a criminal defense attorney specializing in cannabis law. She says there's been a push for a law like this for years. "In 13 years I've gotten hundreds of calls from people who were denied a job even when they disclosed it up front it didn't make a difference that it was medical." Click here to read the full story and watch the interview on the KGTV website.

Cannabis Branding: On the Edge of the Metaverse

Photo by julien Tromeur on Unsplash Branding in the Metaverse is all the rage. In the last three months alone, well-known brands like Nike, Converse, New Balance, Vineyard Vines, Tahari, Anthropologie, Hollister, Abercrombie & Fitch, and, even Walmart, have all filed applications with the United States Patent and Trademark Office  for intent-to-use trademarks in connection with “digital goods;”# opportunistic filings by individuals not affiliated with name brands have appeared in Classes 9, 35, and 41# for both PRADA and GUCCI; and Metaverse Law, a clever California law firm has been diligently going through the motions in their attempt to trademark the very word on everyone’s lips. But what is Metaverse, and why should you, the owner of the expertly cultivated flower brand, or producer of the most delicately infused edibles care? Metaverse is a virtual world meant to support decentralized, persistent three-dimensional environments, and accessible by anyone with a smart phone, gam

Cannabis Law Institute Opening Keynote - District of Columbia Attorney General Karl Racine #CLI2022

Each year, the  International Cannabis Bar Association hosts the Cannabis law Institute , where the leading minds in law convene for a multi-day, immersive educational and networking event. Offering CLE credit in the United States and select other jurisdictions, CLI covers a multitude of topics in educational sessions interspersed with networking luncheons, off-site events, receptions, and committee and leadership meetings to inform your legal practice. In its fifth year, INCBA's CLI has emerged at the do-not-miss event legal event of the year, where relationships are formed, and key insights are provided. Our Fifth Annual Cannabis Law Institute featured an opening keynote by District of Columbia Attorney General, Karl A. Racine . AG Racine has been a public supporter of decriminalizing cannabis since his election in 2014 and has supported both banking initiatives as well as regulation of DC's decriminalized but unregulated cannabis industry since 2019. With his unique persp

Diversity in the Cannabis Industry - it's more than checking the box

  June 30, 2022 12:30-2PM Eastern/11:30AM-1PM Central CICK HERE TO REGISTER Discover what your clients are missing about diversity in the cannabis industry – including how to address issues unique to this industry. You will hear from a diverse panel of cannabis business owners and executives about their experiences and learn tips for keeping your clients on the right side of this issue. Prep for this with this article from Marijuana Business Journal found in The Cannabis NewsHub . We are proud to be content providers and supporters of ABA Moderator:   Susan Burns , S Burns Legal PLLC Panelists: Steven Brown , CEO, Nothing But Hemp LLC Angela Dawson , CEO and co-founder, 40 Acres Co-op Amber Littlejohn , Executive Director, Minority Cannabis Business Association Maggie May Wilson , CMO, Fruit Slabs Lici Zimmerman Co-Sponsored by the ABA TIPS Cannabis Committee